On February 8, 2018 Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, reported that Tito A. Serafini, Ph.D., Chief Executive Officer and Co-Founder, will participate in a panel discussion on immuno—oncology being held during the 2018 BIO CEO & Investor Conference on Monday, February 12, 2018, from 9:00 AM to 10:15 AM ET in New York, NY (Press release, Atreca, FEB 7, 2018, View Source [SID1234523818]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The panel, titled "Immuno-Oncology Milestone’s to Come: Pipelines Beyond CAR-T 1.0", will take place at the New York Marriott Marquis.